What is the appropriate enoxaparin (Lovenox) dosing for venous thromboembolism prophylaxis in a 70-year-old female smoker with a suspected hip fracture?

Enoxaparin Dosing for Hip Fracture VTE Prophylaxis

For a 70-year-old female smoker with a suspected hip fracture, initiate enoxaparin 40 mg subcutaneously once daily immediately and continue for at least 4 weeks postoperatively.

Dosing Recommendation

The standard prophylactic dose is enoxaparin 40 mg subcutaneously once daily 1, 2, 3. This regimen should be:

• Started immediately upon diagnosis of hip fracture (even before surgery)
• Continued throughout hospitalization until the patient is fully ambulatory
• Extended for at least 4 weeks postoperatively 4

The AAOS hip fracture guidelines provide strong evidence (moderate strength) that VTE prophylaxis should be used in all hip fracture patients, and the case example specifically demonstrates use of Lovenox for 4 weeks postoperatively 4.

Alternative Dosing Strategy

An alternative FDA-approved regimen is enoxaparin 30 mg subcutaneously every 12 hours, initiated 12-24 hours after surgery 3. However, the once-daily 40 mg dosing is simpler for outpatient compliance and is the preferred regimen in most guidelines 1, 2.

Critical Timing Considerations

If surgery is planned with neuraxial (spinal/epidural) anesthesia:

• Do NOT administer prophylactic LMWH within 10-12 hours before the procedure
• After surgery, the first dose can be given 6-8 hours postoperatively
• After epidural catheter removal, wait at least 2 hours before administering LMWH 5

This timing is crucial to minimize the risk of spinal/epidural hematoma, which carries devastating neurological consequences.

Patient-Specific Factors to Assess

Renal function is critical - enoxaparin is renally cleared and accumulates in renal insufficiency:

• If creatinine clearance <30 mL/min: reduce dose to 30 mg once daily 6
• If CrCl 30-50 mL/min: consider dose reduction or monitoring anti-Xa levels 6
• The manufacturer specifically recommends dose adjustment only for severe renal impairment (CrCl <30 mL/min) 3

Weight considerations:

• Standard fixed dosing (40 mg daily) is inadequate in 33-43% of trauma patients 7, 8
• If the patient is significantly overweight or has other high-risk features (acetabular involvement, prolonged surgery), consider weight-based dosing at 0.5 mg/kg subcutaneously twice daily 7, 9, 8
• For extremely underweight patients (<40 kg), consider weight-based dosing (0.5 mg/kg daily) with anti-Xa monitoring 10

Smoking status does not alter enoxaparin dosing but increases overall VTE risk, reinforcing the need for prophylaxis.

Monitoring and Dose Adjustment

Routine coagulation monitoring is NOT required for standard prophylactic dosing 3. However, consider anti-Xa level monitoring (goal 0.2-0.4 IU/mL for prophylaxis) in:

• Severe renal impairment (CrCl <30 mL/min)
• Extremes of body weight
• High-risk fracture patterns (acetabular, prolonged surgery)
• Bleeding complications

Research shows that 43% of orthopedic trauma patients receiving standard 30 mg twice daily dosing had subtherapeutic anti-Xa levels, and those with low levels had significantly higher 90-day DVT (12% vs 1.4%) and PE rates (8% vs 0%) 7.

Bleeding Risk Assessment

Contraindications to enoxaparin:

• Active major bleeding
• Severe thrombocytopenia (<50,000/μL)
• History of heparin-induced thrombocytopenia (HIT)

If bleeding risk is high but VTE prophylaxis still needed:

• Use mechanical prophylaxis (sequential compression devices, graduated compression stockings) until bleeding risk decreases 2
• Then initiate pharmacologic prophylaxis once hemostasis is assured

Major bleeding rates with enoxaparin 40 mg daily in hip surgery are low (0-4%) 3, and a recent comparative study showed aspirin had lower transfusion requirements but similar VTE rates 11.

Duration of Prophylaxis

Extended prophylaxis for 4 weeks is strongly recommended for hip fracture surgery 1, 4. The AAOS guidelines specifically state this duration in their case examples, and the risk of VTE remains elevated throughout the recovery period 4.

Common Pitfalls to Avoid

1. Delaying prophylaxis - Start immediately upon diagnosis, not just postoperatively
2. Inadequate duration - Continue for full 4 weeks, not just hospital stay
3. Ignoring renal function - Always check CrCl in elderly patients; dose reduction is mandatory if <30 mL/min
4. Fixed dosing in high-risk patients - Consider weight-based dosing (0.5 mg/kg BID) for obese patients or complex fractures
5. Timing errors with neuraxial anesthesia - Respect the 10-12 hour window to prevent catastrophic spinal hematoma